|
Market Closed -
Japan Exchange
02:30:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 2,417.00 JPY | +1.15% |
|
-0.14% | +15.48% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,334B 27.85B 23.97B 22.49B 20.58B 38.4B 2,633B 38.71B 266B 104B 1,346B 105B 102B | P/E 2027 * |
11.7x | P/E 2028 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4,275B 27.47B 23.64B 22.18B 20.3B 37.88B 2,597B 38.18B 262B 102B 1,327B 103B 101B | EV / Sales 2027 * |
1.84x | EV / Sales 2028 * | 1.79x |
| Free-Float |
98.88% | Yield 2027 * |
3.32% | Yield 2028 * | 3.43% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
OTC Markets
| ALPMF | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript : Astellas Pharma Inc.
| 1 day | +1.15% | ||
| 1 week | -0.14% | ||
| Current month | +1.92% | ||
| 1 month | +9.76% | ||
| 3 months | +11.41% | ||
| 6 months | -2.72% | ||
| Current year | +15.48% |
| 1 week | 2,330.5 |  | 2,430.5 |
| 1 month | 2,125 | | 2,455 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 64 | 2019-05-31 |
| Director/Board Member | 59 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.15% | -0.14% | +45.69% | +9.86% | 27B | |
| +0.00% | -1.29% | +57.34% | +107.97% | 1,034B | |
| +0.96% | +4.64% | +56.24% | +73.08% | 663B | |
| -0.35% | +1.04% | +23.11% | +78.53% | 462B | |
| +2.09% | -2.06% | +32.28% | +38.37% | 344B | |
| 0.00% | +5.36% | +27.40% | +47.50% | 307B | |
| +1.42% | +0.26% | -0.52% | +13.62% | 251B | |
| +0.22% | +1.70% | +56.57% | +74.97% | 239B | |
| -0.03% | +2.13% | -17.30% | -53.99% | 207B | |
| +0.39% | +0.87% | +32.89% | +99.77% | 186B | |
| Average | +0.72% | -0.76% | +31.37% | +48.97% | 372.04B | |
| Weighted average by Cap. | +0.59% | -0.84% | +38.69% | +68.05% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,329B 14.97B 12.88B 12.09B 11.06B 20.64B 1,415B 20.8B 143B 55.69B 723B 56.22B 54.99B | 2,155B 13.85B 11.92B 11.19B 10.23B 19.1B 1,310B 19.25B 132B 51.53B 669B 52.02B 50.89B |
| Net income | 356B 2.29B 1.97B 1.85B 1.69B 3.15B 216B 3.18B 21.84B 8.51B 110B 8.59B 8.4B | 333B 2.14B 1.84B 1.73B 1.58B 2.95B 202B 2.97B 20.42B 7.95B 103B 8.03B 7.85B |
| Net Debt | -59.18B -380M -327M -307M -281M -524M -35.96B -529M -3.63B -1.41B -18.37B -1.43B -1.4B | -481B -3.09B -2.66B -2.49B -2.28B -4.26B -292B -4.29B -29.51B -11.49B -149B -11.6B -11.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | JP¥2,417.00 | +1.15% | 4,891,400 |
| 26-09-02 | JP¥2,389.50 | -1.04% | 6,357,100 |
| 26-09-01 | JP¥2,414.50 | +1.81% | 5,726,800 |
| 26-08-31 | JP¥2,371.50 | +0.04% | 15,498,500 |
| 26-08-28 | JP¥2,370.50 | -0.86% | 6,036,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
